相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value
Maria Morales-Lozano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
Elena Zamagni et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Luciano J. Costa et al.
BLOOD ADVANCES (2021)
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma
Bastien Jamet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
Nikhil C. Munshi et al.
BLOOD ADVANCES (2020)
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Jens Hillengass et al.
LANCET ONCOLOGY (2019)
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
Faith E. Davies et al.
HAEMATOLOGICA (2018)
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
Faith E. Davies et al.
HAEMATOLOGICA (2018)
Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma
James E. McDonald et al.
CLINICAL CANCER RESEARCH (2017)
Integration of Novel Agents into the Care of Patients with Multiple Myeloma
Robert Z. Orlowski et al.
CLINICAL CANCER RESEARCH (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
Elena Zamagni et al.
CLINICAL CANCER RESEARCH (2015)
11C-Methionine-PET: A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
Katharina Lückerath et al.
Oncotarget (2015)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
Kenneth Clark et al.
JOURNAL OF DIGITAL IMAGING (2013)
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
Elena Zamagni et al.
BLOOD (2011)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation
AC Rawstron et al.
BLOOD (2002)
分享论文
